NantKwest stock: buy or sell?

NK stock price: $7.35 -0.41% At close on January 17th, 2020

Updated on:
January 17th, 2020


After boosting an astounding 28.18% on Jan 16th, NantKwest closed yesterday at $7.35 and declined a bad -0.41%. On Tuesday NK plummed a bloodcurdling -38.78%.

NantKwest, Inc., a clinical-stage immunotherapy biotechnology company, develops immunotherapeutic treatments for cancer, infectious diseases, and inflammatory diseases in the United States.

Should I buy NantKwest stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to choose your own trading plan that matches with your character as inversor. At, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with NantKwest stock situation right now, hence this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean NK will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is NantKwest stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. Unfortunately, we couldn't detect any rating for NK stock for the last month.

NantKwest stock analysis

Daily outlook

After boosting an astounding 28.18% on January 16th, NantKwest closed yesterday at $7.35 and declined a bad -0.41%.

After boosting an astounding 28.18% on January/16, NantKwest closed yesterday at $7.35 and declined a bad -0.41%. Since price and SMA200d lines crossed up on November, NK climbed $6.17 (522.88%). Since SMA100d and SMA200d crossed up on November, NK price climbed $6.30 per share (600.00%).

NK stock chart (daily)

Weekly outlook

After sliding a chilling -13.48% in a week last week, NantKwest closed this week at $7.35 and skyrocketed an exceptional 106.46%.

NantKwest stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Since price and SMA40w lines crossed up by mid November 2019, NK climbed $6.25 (568.18%). Late October 2019, SMA20w and SMA40w crossed up triggering a rise of 533.62%.

NK stock chart (weekly)

NantKwest stock price history

NantKwest IPO was on September 2nd, 2014 at $0.02 per share1. Since then, NK stock surged a 36,650.00%, with a yearly average of 7,330.00%. If you had invested $1,000 in NantKwest stock in 2014, it would worth $366,500.00 today.

1: Adjusted price after possible price splits or reverse-splits.

NantKwest stock historical price chart

NK stock reached 52-week highs on Jan/16 at $9.90, and all-time highs 2015-07-28 with a price of 38.48.

NantKwest stock price target

How much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' NK stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not detected any price target for NantKwest stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

Since last April, when NantKwest posted its last earnings report, it . Unfortunately, reported EPS is not yet available in our database.
NK earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In 2018, NantKwest annual revenues raised a beatiful 4.44% to $0.05 M dollars from $0.05 marked in 2017. When comparing 2018 vs 2017, slightly better, profit margin (that is, the net income divided by revenues) skyrocketed a 9,537.16% to -204,736.17%.

NK annual Sales and Income evolution
2013$0.60 M-$-2.05 M-341.7%-
2014$0.64 M6.83%$-6.21 M-969.3%203.07%
2015$0.24 M-63.18%$-236.88 M-100371.2%3,712.59%
2016$0.04 M-81.36%$-120.81 M-274565.9%-49.00%
2017$0.05 M2.27%$-96.42 M-214273.3%-20.19%
2018$0.05 M4.44%$-96.23 M-204736.2%-0.20%

Quarterly financial results

NantKwest posted $0.01 million in sales for 2018-Q4, a -77.42% less compared to previous quarter. Reported quarter earnings marked $-17.34 million with a profit margin of -247,714.29%. Profit margin collapsed a -171,472.35% compared to previous quarter when profit margin was -76,241.94%. When comparing sales to same quarter last year, NantKwest sales marked a frightening slide and plummed a -41.67%.
NK quarterly Sales and Income evolution
2017-Q1$0.01 M-$-24.52 M-222909.1%-
2017-Q2$0.01 M27.27%$-23.45 M-167500.0%-4.36%
2017-Q3$0.01 M-42.86%$-23.97 M-299612.5%2.21%
2017-Q4$0.01 M50.00%$-24.49 M-204058.3%2.16%
2018-Q1$0.01 M-58.33%$-27.52 M-550380.0%12.38%
2018-Q2$0.00 M-20.00%$-27.73 M-693300.0%0.77%
2018-Q3$0.03 M675.00%$-23.64 M-76241.9%-14.77%
2018-Q4$0.01 M-77.42%$-17.34 M-247714.3%-26.63%

NantKwest ownership

When you are planning to invest in shares of a stock, it's always worth to overview its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For NantKwest, 71.81% of all outstanding shares are owned by its staff.

In case of NantKwest stock, 5.72% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for NK stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to NantKwest:

Market cap$723.0 M$3.0 B$601.5 M
Total shares98.4 M99.0 M43.9 M
Float shares34.0 M94.1 M20.8 M
  - Institutional holdings (%)5.7%86.2%64.8%
  - Insider holdings (%)71.8%0.9%14.2%
Shares in short selling0.0%0.0%0.0%

NantKwest summary

Friday, January 17th, 2020
Day range$6.75 - $8.36
Previous close$7.38
Session gain-0.41%
Average true range$1.18
50d mov avg$2.72
100d mov avg$1.97
200d mov avg$1.57
Daily pattern
Weekly pattern lt06a

NantKwest performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We compared NantKwest against Momenta Pharmaceuticals and Molecular Templates in the following table:
MNTAMomenta Pharmaceu...112.50%218.75%151.64%
MTEMMolecular Templat...74.43%85.27%224.88%

NantKwest competitors

Creating a list of competitors for NantKwest it's difficult. We selected 2 public companies that are related to and can be considered as competitors of NantKwest: